| Literature DB >> 32102533 |
Vanshika Makkar1, Mala Kamboj1, Anjali Narwal1, Rajeev Kumar Kapoor2.
Abstract
OBJECTIVE: Oral cancer usually has an early precancerous stage before its actual malignant transformation. Although there are various approaches to diagnose early stages of cancer, yet there is one less explored, cost effective and simple technique known as crystallization test. The aim of the study was to reaffirm the effectiveness of Pfeiffer's crystallization test in screening oral leukoplakia and squamous cell carcinoma.Entities:
Keywords: Crystallization test; Diagnostic test; Oral Squamous Cell Carcinoma and Transverse form; Oral leukoplakia
Mesh:
Substances:
Year: 2020 PMID: 32102533 PMCID: PMC7332126 DOI: 10.31557/APJCP.2020.21.2.517
Source DB: PubMed Journal: Asian Pac J Cancer Prev ISSN: 1513-7368
Figure 1A, Cupric Chloride Crystals Alone; B, Crystallization Pattern of Normal Blood
Figure 2A, Crystallization Pattern Observed in OL; B, Crystallization Pattern Observed in OSCC
Figure 3Various Transverse form Patterns A, Horizontal Bar; B, Star; C, Fanning
Results of Crystallization Test
| Crystallization Test Results | Diagnosis | Total | ||
|---|---|---|---|---|
| Diseased | Non-Diseased | |||
| III* (n=65) | II* (n=50) | I (n=60) | (n=175) | |
| Positive | 61 | 40 | 17 | 118 |
| Negative | 4 | 10 | 43 | 57 |
| Sensitivity | 93.84% | 80% | - | - |
| False Negative | 6.15% | 20% | - | - |
| Specificity | - | - | 71.66% | - |
| False Positive | - | - | 28.33% | - |
* Biopsy Proven Cases; Positive predictive value (PPV) and Negative predictive value (NPV) of Crystallization test in detecting OL is 70.17% and 81.13% respectively; PPV and NPV of Ct in detecting OSCC is 78.20% and 91.48% respectively.
Comparison of Mean and Total Transverse Forms among the Groups*
| Group | Transverse Form | No. of Total TF | Mean TF ± SD | ||
|---|---|---|---|---|---|
| Horizontal Bar | Star | Fanning | |||
| I | 17 | 3 | 9 | 29 (8.55%) | 0.483±0.85 |
| II | 18 | 44 | 40 | 102 (30.08%) | 2.04±1.3 |
| III | 81 | 75 | 52 | 208 (60.42%) | 3.07±1.75 |
H value – 74.474, df = 2, p value – 0.000
Details of Study Participants in Group II and Group III
| Clinical Appearance Group II | ||||
|---|---|---|---|---|
| Thin smooth | Thick fissured | Granular verruciform | Erythro-leukoplakia | |
| No. of Cases | 3 | 33 | 1 | 13 |
| Positive crystallization | 3 | 24 | 1 | 12 |
| Histopathological Diagnosis Group II | ||||
| Hyperkeratosis with no dysplasia | Mild dysplasia | Moderate dysplasia | Severe dysplasia | |
| No of case | 3 | 34 | 12 | 1 |
| Positive crystallization | 2 | 26 | 11 | 1 |
| Clinical Staging Group III | ||||
| TNM Stage I | TNM Stage II | TNM Stage III | TNM Stage IV | |
| No. of cases | 10 | 26 | 16 | 13 |
| Positive crystallization | 9 | 25 | 15 | 12 |
| Histopathological Diagnosis Group III | ||||
| Well differentiated SCC | Moderately differentiated SCC | |||
| No. of cases | 41 | 24 | ||
| Positive crystallization | 38 (92.68%) | 23 (95.83%) | ||